Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

AACR 2022 | Anti-CAIX immune restoring CAR T-cells reverse immunosuppressive TME

Yufei Wang, PhD, Dana-Farber Cancer Institute, Boston, MA, discusses the use of an anti-CAIX Immune Restoring (IR) CAR-T cell in an orthotopic humanized NSG-SGM3 mouse model. This approach displays superior antitumor activity and reverses the immunosuppressive tumor microenvironment in a humanized clear cell renal carcinoma mouse model. This interview took place at the American Association for Cancer Research Annual Meeting in New Orleans, LA.

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.